N/A
Completed N=69
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
Source: ClinicalTrials.gov NCT04912895 ↗Enrolled (actual)
69
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcomePrimary: Sensitivity of Detecting SARS-CoV-2 RNA — 31; 0 Participants
Summary
The purpose of this study is to learn how to better detect infection and understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes lung disease and is spread. The novel device called PneumoniaCheck is a safe way to collect material from the lung from coughs. Study participants will collect cough specimens over a 24 hour period.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Sensitivity of Detecting SARS-CoV-2 RNA |
31; 0 | — |
| PRIMARY Specificity of Detecting SARS-CoV-2 RNA |
10; 18 | — |
Eligibility Criteria
Inclusion Criteria
- Being treated for an acute respiratory illness either as inpatients or outpatients at Emory University Hospital
- English is a primary spoken language
Exclusion Criteria
- none
Inclusion Criteria for Healthy Volunteers:
- Prior registration in an adult participant database and agreed to be contacted for future studies
- English is a primary spoken language
Data sourced from ClinicalTrials.gov (NCT04912895). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.